
Shakun Pharma Private Limited
About Shakun Pharma Private Limited
Data last updated:
Shakun Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 September 2001.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U45100MH2001PTC133295.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.03 Lakh. It was led by directors Surbhit Mukesh Shah and Amit Mukesh Shah.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 1st Floor – 1 Plot 161 Masalawala Buildling Kika Street Gulalwadi Girgaon, Mumbai, Maharashtra, India – 400004.
As per the financials filed for FY 2021, the company reported a revenue of ₹8.02 Lakh.
Company details
CIN history
Shakun Pharma has one previous CIN (Corporate Identification Number): U24239MH2001PTC133295. The current CIN is U45100MH2001PTC133295, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U45100MH2001PTC133295 | Current |
| U24239MH2001PTC133295 | Previous |
Contact details
Shakun Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address1st Floor – 1 Plot 161 Masalawala Buildling Kika Street Gulalwadi Girgaon, Mumbai, Maharashtra, India – 400004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shakun Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shakun Pharma Private Limited
FY 2023 filings availableShakun Pharma Private Limited reported revenue of ₹8.02 Lakh for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹8.02 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shakun Pharma Private Limited, buy the company report.
Board of directors of Shakun Pharma Private Limited
Shakun Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surbhit Mukesh Shah Also directs: Rekvina Laboratories Limited, Radiant Parenterals Limited, Rekvina Pharmaceuticals (India) Private Limited and 2 more | Director | 16 Sep 2016 | 10 Years 1 Months | As last reported |
| Amit Mukesh Shah Also directs: Rekvina Laboratories Limited, Radiant Parenterals Limited, Rekvina Pharmaceuticals (India) Private Limited and 3 more | Director | 16 Sep 2016 | 10 Years 1 Months | As last reported |
Peer comparison
Shakun Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| PRK Pharmanlysts Private Limited | ₹8.07 Lakh (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Human Tissue Technology Private Limited | ₹8.06 Lakh (FY 2025) | 48.0% | Ahmedabad, Gujarat, India | |||
| Wockridge Global Healthcare Private Limited | ₹8.06 Lakh (FY 2025) | -85.0% | Mumbai, Maharashtra, India | |||
| Med-Ortheve Healthcare Private Limited | ₹8.05 Lakh (FY 2023) | Moshi, Maharashtra, India | ||||
| Sangus Life Science Private Limited | ₹8.02 Lakh (FY 2022) | -12.0% | Patna, Bihar, India | |||
| Shakun Pharma Private Limitedthis company | ₹8.02 Lakh (FY 2021) | Mumbai, Maharashtra, India | ||||
| Midas Care Holdings Pvt Ltd | ₹7.97 Lakh (FY 2017) | -46.0% | Mumbai, Maharashtra, India | |||
| Hetsym Pharma Private Limited | ₹7.92 Lakh (FY 2025) | 75661.0% | Hyderabad, Telangana, India | |||
| Brainichem Formulations Private Limited | ₹7.88 Lakh (FY 2024) | -25.0% | Udhna, Gujarat, India | |||
| Yashoda Upskill Academy Private Limited | ₹7.86 Lakh (FY 2025) | -58.0% | Hyderabad, Telangana, India | |||
| Oncosys Formulations Private Limited | ₹7.83 Lakh (FY 2025) | 27.0% | Varanasi, Uttar Pradesh, India |
To see the full peer comparison of Shakun Pharma Private Limited, buy the company report.
Auditor
Shakun Pharma Private Limited is audited by JIGAR ADHYARU & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JIGAR ADHYARU & CO | FY 2021 | 142223W |
Shareholding
The shareholding of Shakun Pharma Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shakun Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shakun Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shakun Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shakun Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shakun Pharma Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Ila Rajendra Pathak ceased to be Director on 05 Jun 2019.
Frequently asked questions
Shakun Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Shakun Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 06 September 2001 and is registered under CIN U45100MH2001PTC133295. The company has been struck off by the Registrar of Companies and is no longer operational.
Shakun Pharma had 2 directors:
- Surbhit Mukesh Shah - Director
- Amit Mukesh Shah - Director
The CIN (Corporate Identification Number) of Shakun Pharma is U45100MH2001PTC133295. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Shakun Pharma is at 1st Floor – 1 Plot 161 Masalawala Buildling Kika Street Gulalwadi Girgaon, Mumbai, Maharashtra, India – 400004.
Shakun Pharma was incorporated on 06 September 2001. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Shakun Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
Shakun Pharma operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
The peers of Shakun Pharma by revenue are PRK Pharmanlysts Private Limited, Human Tissue Technology Private Limited, Wockridge Global Healthcare Private Limited, Med-Ortheve Healthcare Private Limited, Sangus Life Science Private Limited and 5 more, all in the Pharma industry (Formulations).
Ila Rajendra Pathak ceased to be Director on 05 Jun 2019. Viral Jitendra Doshi ceased to be Director on 05 Jun 2019. Amit Mukesh Shah ceased to be Additional Director on 30 Sep 2016. Shakun Pharma has 6 board changes on record in total.
The compliance status of Shakun Pharma is compliant as of 25 August 2026.